ID

35324

Description

Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01980888

Link

https://clinicaltrials.gov/show/NCT01980888

Keywords

  1. 2/28/19 2/28/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 28, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Lymphocytic Leukemia NCT01980888

Eligibility Chronic Lymphocytic Leukemia NCT01980888

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented diagnosis of b-cell cll, with diagnosis established according to international workshop on chronic lymphocytic leukemia (iwcll)
Description

Chronic Lymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023434
no prior therapy for cll other than corticosteroids for disease complications
Description

Prior Therapy Absent Chronic Lymphocytic Leukemia | Exception Adrenal Cortex Hormones Disease complication

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0023434
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001617
UMLS CUI [2,3]
C0544688
cll that warrants treatment
Description

Chronic Lymphocytic Leukemia Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0023434
UMLS CUI [1,2]
C0332121
presence of measurable lymphadenopathy
Description

Lymphadenopathy Measurable

Data type

boolean

Alias
UMLS CUI [1,1]
C0497156
UMLS CUI [1,2]
C1513040
eastern cooperative oncology group (ecog) performance status of ≤ 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known histological transformation from cll to an aggressive lymphoma (ie, richter transformation)
Description

Chronic lymphocytic leukaemia transformation Aggressive lymphoma | Richter's syndrome

Data type

boolean

Alias
UMLS CUI [1,1]
C1142081
UMLS CUI [1,2]
C1332225
UMLS CUI [2]
C0349631
known presence of myelodysplastic syndrome
Description

MYELODYSPLASTIC SYNDROME

Data type

boolean

Alias
UMLS CUI [1]
C3463824
evidence of ongoing systemic bacterial, fungal, or viral infection at the time of randomization
Description

Systemic bacterial infection | Systemic mycosis | Systemic viral infection

Data type

boolean

Alias
UMLS CUI [1]
C4285778
UMLS CUI [2]
C0553576
UMLS CUI [3]
C4285789
ongoing liver injury
Description

Injury of liver

Data type

boolean

Alias
UMLS CUI [1]
C0160390
history of non-infectious pneumonitis
Description

Non-infectious pneumonia

Data type

boolean

Alias
UMLS CUI [1]
C0264376
ongoing inflammatory bowel disease
Description

Inflammatory Bowel Disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390
history of prior allogeneic bone marrow progenitor cell or solid organ transplantation
Description

Bone Marrow Stem Cell Transplantation Allogeneic | Solid organ transplant

Data type

boolean

Alias
UMLS CUI [1,1]
C0842093
UMLS CUI [1,2]
C1515895
UMLS CUI [2]
C0730400
ongoing immunosuppressive therapy other than corticosteroids
Description

Therapeutic immunosuppression | Exception Adrenal Cortex Hormones

Data type

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001617
received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
Description

Study Subject Participation Status | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT01980888

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Lymphocytic Leukemia
Item
documented diagnosis of b-cell cll, with diagnosis established according to international workshop on chronic lymphocytic leukemia (iwcll)
boolean
C0023434 (UMLS CUI [1])
Prior Therapy Absent Chronic Lymphocytic Leukemia | Exception Adrenal Cortex Hormones Disease complication
Item
no prior therapy for cll other than corticosteroids for disease complications
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C0544688 (UMLS CUI [2,3])
Chronic Lymphocytic Leukemia Treatment required for
Item
cll that warrants treatment
boolean
C0023434 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Lymphadenopathy Measurable
Item
presence of measurable lymphadenopathy
boolean
C0497156 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chronic lymphocytic leukaemia transformation Aggressive lymphoma | Richter's syndrome
Item
known histological transformation from cll to an aggressive lymphoma (ie, richter transformation)
boolean
C1142081 (UMLS CUI [1,1])
C1332225 (UMLS CUI [1,2])
C0349631 (UMLS CUI [2])
MYELODYSPLASTIC SYNDROME
Item
known presence of myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
Systemic bacterial infection | Systemic mycosis | Systemic viral infection
Item
evidence of ongoing systemic bacterial, fungal, or viral infection at the time of randomization
boolean
C4285778 (UMLS CUI [1])
C0553576 (UMLS CUI [2])
C4285789 (UMLS CUI [3])
Injury of liver
Item
ongoing liver injury
boolean
C0160390 (UMLS CUI [1])
Non-infectious pneumonia
Item
history of non-infectious pneumonitis
boolean
C0264376 (UMLS CUI [1])
Inflammatory Bowel Disease
Item
ongoing inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
Bone Marrow Stem Cell Transplantation Allogeneic | Solid organ transplant
Item
history of prior allogeneic bone marrow progenitor cell or solid organ transplantation
boolean
C0842093 (UMLS CUI [1,1])
C1515895 (UMLS CUI [1,2])
C0730400 (UMLS CUI [2])
Therapeutic immunosuppression | Exception Adrenal Cortex Hormones
Item
ongoing immunosuppressive therapy other than corticosteroids
boolean
C0021079 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
Study Subject Participation Status | Investigational New Drugs
Item
received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial